Ryman Healthcare closes upsized NZ$150M retail bond offer
What's the deal? New Zealand retirement care operator Ryman HealthcareDealroom has a profile for this one. Try Dealroom → has closed a NZ$150M retail bond offer, upsized from an original NZ$100M target after strong investor demand. The six-year fixed-rate bonds, maturing on June 22, 2032, carry an interest rate of 5.72% per annum. The offer was fully subscribed within 48 hours and closed after 72.
The bonds were offered to institutional investors and New Zealand retail investors, with Ryman exercising its discretion to accept NZ$50M in oversubscriptions.
Why now? Ryman is in the midst of a financial turnaround. The company reported its first positive free cash flow in over a decade — NZ$188M — in its FY26 annual report, covering the period from April 2025 to March 2026. EBITDAF rose 94% to NZ$88M.
The bond offer follows a series of balance-sheet moves. In February 2025, Ryman announced a NZ$1B equity raise to repay existing debt. It also completed a NZ$902.4M equity raise in March 2023. In early 2026 the company sold a Melbourne development site approved for a NZ$155M retirement complex for A$30.85M.
Chief executive officer Naomi James said the offer "re-established Ryman as a repeat issuer in the bond market," adding that the company plans to return as it continues diversifying its funding sources.
What could go wrong? Ryman carries significant debt, and the retirement care sector is capital-intensive. The company's turnaround depends on sustained cash flow from developments and operational improvements. Any slowdown in the New Zealand or Australian property markets could pressure those returns.
The 5.72% coupon also reflects the cost of that capital — Ryman is paying a 1.80% margin over the swap rate, a premium that signals the market still prices in some risk.
The signal: Ryman's ability to fully subscribe a NZ$150M bond offer within 48 hours — and upsize it by 50% — stands in stark contrast to a company that needed NZ$902.4M in equity in 2023 and another NZ$1B raise in early 2025 just to reset its balance sheet. The pivot from dilutive equity raises to oversubscribed debt issuance, backed by its first positive free cash flow in over a decade, suggests the mature operator has crossed a credibility threshold with capital markets that could give it a meaningful funding advantage over smaller aged-care peers still locked out of bond markets.
Read more: The Weekly Source
